MAPT and Alzheimer disease: Subjects who were stratified to high tau on the majority visual read had a significantly higher AD-signature SUVr than those who were stratified to non–high tau (1.67 ± 0.25 vs. 1.21 ± 0.29, Supplemental Fig. 2).